Clinical Study Results
The websites listed at the end of this summary may have other information about
adverse reactions or other medical problems that happened during this study.
Some participants did not complete all of the treatment periods. So, the results
below include information for 20 participants in each treatment period.
How many participants had serious adverse reactions?
None of the participants had serious adverse reactions during this study.
How many participants had adverse reactions?
• 20% of participants had adverse reactions during Treatment Period A of the
study. This was 4 out of 20 participants.
• 15% of participants had adverse reactions during Treatment Period B of the
study. This was 3 out of 20 participants.
• 10% of participants had adverse reactions during Treatment Period C of the
study. This was 2 out of 20 participants.
• 20% of participants had adverse reactions during Treatment Period D of the
study. This was 4 out of 20 participants.
• 10% of participants had adverse reactions during Treatment Period E of the
study. This was 2 out of 20 participants.
• 10% of participants had adverse reactions during Treatment Period F of the
study. This was 2 out of 20 participants.
None of the participants left the study because of adverse reactions they had.
8